Alliance Pharma (LON:APH) Share Price Crosses Below 200 Day Moving Average of $39.04

Alliance Pharma plc (LON:APH) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 39.04 ($0.49) and traded as low as GBX 37.10 ($0.46). Alliance Pharma shares last traded at GBX 37.25 ($0.46), with a volume of 441,309 shares changing hands.

Analysts Set New Price Targets

Separately, Royal Bank of Canada dropped their price target on Alliance Pharma from GBX 65 ($0.81) to GBX 60 ($0.75) and set an “outperform” rating on the stock in a research note on Wednesday, January 31st.

Alliance Pharma Stock Up 0.8 %

The company has a current ratio of 1.93, a quick ratio of 1.42 and a debt-to-equity ratio of 45.00. The stock has a market cap of £197.79 million, a P/E ratio of -3,640.00, a PEG ratio of 1.04 and a beta of 0.60. The firm has a 50-day simple moving average of GBX 39.24 and a two-hundred day simple moving average of GBX 38.96.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.